Yu Shi

METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma

Xiangyu Zeng, Fei Zhao, Gaofeng Cui et al. · Nature Cancer · 2022 · 68 citations

Medicine, Molecular Biology, Oncology +15

Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells

Yu Shi, Liankang Sun, Rui Zhang et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 64 citations · Full text

Medicine, Cancer Biology, Oncology +17

Hypoxia induced changes in miRNAs and their target mRNAs in extracellular vesicles of esophageal squamous cancer cells

Fangyu Chen, Li Chu, Jie Li et al. · Thoracic Cancer · 2020 · 47 citations · Full text

Medicine, Cell Biology, Oncology +17

α‐Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades

Yu Shi, Yangwei Fan, Yuan Hu et al. · Journal of Cellular and Molecular Medicine · 2019 · 45 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway

Yangwei Fan, Mengya Li, Ke Ma et al. · Cancer Biology & Therapy · 2018 · 31 citations · Full text

Medicine, Oncology, Pharmacology +16